For the thirteenth consecutive year, Challenges has published its selection of "100 start-ups to invest in".
The start-ups from Erganeo, Orixha, Evora Biosciences and Icon Photonics are included for this year 2022 in the Deeptech, Medtech and Biotech sectors.
Evora Biosciences develops exosome-based treatments, the next generation of subcellular therapies. (Université Paris Cité)
Orixha has developed a solution for the health of the critical patient, thanks to Total Liquid Ventilation. This medical device is unique in the world.
Icon Photonics offers innovative solutions in the fields of optical coupling and encapsulation. (Gustave Eiffel University)
Erganeo congratulates its start-ups for this nomination.
To know more about this nomination
